Jéssica Barbosa

Ms. Jéssica Barbosa

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Susana BragaSusana Braga
Susana Braga
JBJéssica Barbosa
Jéssica Barbosa
NSNádia Santos
Nádia Santos
FEFiras El-Saleh
Firas El-Saleh
Filipe Almeida PazFilipe Almeida Paz
Filipe Almeida Paz
The present review describes the various roles of cyclodextrins (CDs) in vaccines against viruses and in antiviral therapeutics. The first section describes the most commonly studied application of cyclodextrins—solubilisation and stabilisation of antiviral drugs; some examples also refer to their beneficial taste-masking activity. The second part of the review describes the role of cyclodextrins in antiviral vaccine development and stabilisation, where they are employed as adjuvants and cryopreserving agents. In addition, cyclodextrin-based polymers as delivery systems for mRNA are currently under development. Lastly, the use of cyclodextrins as pharmaceutical active ingredients for the treatment of viral infections is explored. This new field of application is still taking its first steps. Nevertheless, promising results from the use of cyclodextrins as agents to treat other pathologies are encouraging. We present potential applications of the results reported in the literature and highlight the products that are already available on the market.

11 April 2016 in Drug Delivery
Verified
Journal Article
Closed access
PDF file
JBJéssica Barbosa
Jéssica Barbosa
Filipe Almeida PazFilipe Almeida Paz
Filipe Almeida Paz
Susana BragaSusana Braga
Susana Braga
Montelukast sodium is a leukotriene antagonist of growing interest as an alternative therapy for asthma across different age groups due to its bronchoprotective, anti-inflammatory and anti-allergic properties. Currently, montelukast is commercialized only in oral solid dosage forms, which are the favourite of adult patients but may pose challenges in administration to children of young age or patients suffering from dysphagia. This review presents a comprehensive revision of scientific reports and patents on emerging strategies for the delivery of montelukast. A common ground to these reports is the pursue of an enhanced montelukast performance, by increasing its bioavailability and physico-chemical stability. A wide variety of strategies can be found, from the formation of supramolecular adducts with cyclodextrins to encapsulation in nanoparticles and liposomes. The new dosage forms for montelukast are designed for non-enteric absorption, some for absorption in the oral cavity and another two being for local action in the nasal mucosa or in the pulmonary epithelium. The review describes the emerging delivery strategies to circumvent the current limitations to the use of montelukast that are expected to ultimately lead to the development of more patient-compliant dosage forms.

18 June 2020 in Molecules
Verified
Journal Article
Open access
PDF file
JBJéssica Barbosa
Jéssica Barbosa
Susana BragaSusana Braga
Susana Braga
Filipe Almeida PazFilipe Almeida Paz
Filipe Almeida Paz
Bisphosphonates (BPs), well-known medicinal compounds used for osteoporosis management, are currently the target of intensive research, from basic pre-formulation studies to more advanced stages of clinical practice. The high demand by the pharmaceutical industry inherently requires an easy, efficient and quick preparation of BPs. Current synthetic procedures are, however, still far from ideal. This work presents a comprehensive compilation of reports on the synthesis of the commercially available bisphosphonates that are pharmaceutical active ingredients. Current limitations to the conventional synthesis are assessed, and paths towards their improvement are described, either through the use of alternative solvents and/or by selecting appropriate ratios of the reactants. Innovative processes, such as microwave-assisted synthesis, are presented as more environmental-friendly and effective methods. The main advantages and setbacks of all syntheses are provided as a way to clarify and promote the development of simpler and improved procedures. Only in this way one will be able to efficiently respond to the future high demand of BPs, mostly due to the increase in life span in occidental countries.

1 January 2020
Verified
Book Chapter
Closed access
JBJéssica Barbosa
Jéssica Barbosa
FFFlávio Figueira
Flávio Figueira
Susana BragaSusana Braga
Susana Braga
FPFilipe A. Almeida Paz
Filipe A. Almeida Paz

1 May 2019 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
JBJéssica Barbosa
Jéssica Barbosa
Mariela NolascoMariela Nolasco
Mariela Nolasco
PRPaulo Ribeiro-Claro
Paulo Ribeiro-Claro
Filipe Almeida PazFilipe Almeida Paz
Filipe Almeida Paz
Susana BragaSusana Braga
Susana Braga